Literature DB >> 27479696

Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.

Arata Fukushima1, Gary D Lopaschuk2.   

Abstract

Alterations in cardiac energy metabolism are an important contributor to the cardiac pathology associated with obesity, diabetes, and heart failure. High rates of fatty acid β-oxidation with cardiac insulin resistance represent a cardiac metabolic hallmark of diabetes and obesity, while a marginal decrease in fatty acid oxidation and a prominent decrease in insulin-stimulated glucose oxidation are commonly seen in the early stages of heart failure. Alterations in post-translational control of energy metabolic processes have recently been identified as an important contributor to these metabolic changes. In particular, lysine acetylation of non-histone proteins, which controls a diverse family of mitochondrial metabolic pathways, contributes to the cardiac energy derangements seen in obesity, diabetes, and heart failure. Lysine acetylation is controlled both via acetyltransferases and deacetylases (sirtuins), as well as by non-enzymatic lysine acetylation due to increased acetyl CoA pool size or dysregulated nicotinamide adenine dinucleotide (NAD+) metabolism (which stimulates sirtuin activity). One of the important mitochondrial acetylation targets are the fatty acid β-oxidation enzymes, which contributes to alterations in cardiac substrate preference during the course of obesity, diabetes, and heart failure, and can ultimately lead to cardiac dysfunction in these disease states. This review will summarize the role of lysine acetylation and its regulatory control in the context of mitochondrial fatty acid β-oxidation. The functional contribution of cardiac protein lysine acetylation to the shift in cardiac energy substrate preference that occurs in obesity, diabetes, and especially in the early stages of heart failure will also be reviewed. This article is part of a Special Issue entitled: The role of post-translational protein modifications on heart and vascular metabolism edited by Jason R.B. Dyck & Jan F.C. Glatz.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes; Fatty acid oxidation; Heart failure; Lysine acetylation; Obesity

Mesh:

Substances:

Year:  2016        PMID: 27479696     DOI: 10.1016/j.bbadis.2016.07.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

1.  Studying the Lysine Acetylation of Malate Dehydrogenase.

Authors:  Sumana Venkat; Caroline Gregory; Jourdan Sturges; Qinglei Gan; Chenguang Fan
Journal:  J Mol Biol       Date:  2017-03-31       Impact factor: 5.469

2.  A Facile Protocol to Generate Site-Specifically Acetylated Proteins in Escherichia Coli.

Authors:  Sumana Venkat; Caroline Gregory; Kexin Meng; Qinglei Gan; Chenguang Fan
Journal:  J Vis Exp       Date:  2017-12-09       Impact factor: 1.355

Review 3.  Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms.

Authors:  Zahra Nochi; Rikke Katrine Jentoft Olsen; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2017-05-17       Impact factor: 4.982

Review 4.  Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance.

Authors:  Evangelos Oikonomou; Konstantinos Mourouzis; Petros Fountoulakis; Georgios Angelos Papamikroulis; Gerasimos Siasos; Alexis Antonopoulos; Georgia Vogiatzi; Sotiris Tsalamadris; Manolis Vavuranakis; Dimitris Tousoulis
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

5.  Acetylation contributes to hypertrophy-caused maturational delay of cardiac energy metabolism.

Authors:  Arata Fukushima; Liyan Zhang; Alda Huqi; Victoria H Lam; Sonia Rawat; Tariq Altamimi; Cory S Wagg; Khushmol K Dhaliwal; Lisa K Hornberger; Paul F Kantor; Ivan M Rebeyka; Gary D Lopaschuk
Journal:  JCI Insight       Date:  2018-05-17

Review 6.  Mechanisms of transcription factor acetylation and consequences in hearts.

Authors:  Devi Thiagarajan; Srinivasan Vedantham; Radha Ananthakrishnan; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Biochim Biophys Acta       Date:  2016-08-17

7.  Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction.

Authors:  Mark J Haykowsky; Barbara J Nicklas; Peter H Brubaker; W Gregory Hundley; Tina E Brinkley; Bharathi Upadhya; J Thomas Becton; Michael D Nelson; Haiying Chen; Dalane W Kitzman
Journal:  JACC Heart Fail       Date:  2018-07-11       Impact factor: 12.035

8.  Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure.

Authors:  Rongli Zhang; Yuyan Shen; Lin Zhou; Panjamaporn Sangwung; Hisashi Fujioka; Lilei Zhang; Xudong Liao
Journal:  J Mol Cell Cardiol       Date:  2017-09-05       Impact factor: 5.000

9.  Circadian rhythms in cardiac metabolic flexibility.

Authors:  Martin E Young; Mary N Latimer
Journal:  Chronobiol Int       Date:  2021-06-23       Impact factor: 2.877

Review 10.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.